Collecting samples for neurofibromatosis tumor research
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This study collects and stores tumor tissue and blood samples from people with neurofibromatosis-related tumors and their close family members, to help researchers better understand these conditions and develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis or suspected diagnosis of a neurofibromatosis-associated tumor (a type of nerve tumor).
- You are an Asian biological parent or full sibling of someone with a neurofibromatosis-associated tumor.
- You are willing to provide samples (tissue, blood) for research.
- You are not non-Asian (must be of Asian background).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study talks with people who have NF1 (and caregivers of children with NF1) about how visible tumors affect them. The goal is to create questionnaires that measure these concerns, which could lead to better support and treatments.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This trial collects tissue samples from people with MPNST or neurofibroma during surgery to find metabolic markers that could help diagnose MPNST faster and ensure complete removal of tumors.
This study collects and reviews past and future health records for adults who have both neurofibromatosis type 1 (NF1) and a brain tumor called glioma. The goal is to better understand these conditions and how they progress, which can help guide future research and care.
This study monitors people with neurofibromatosis type 1 (NF1) over time to watch for signs that their nerve tumors might turn into cancer. It helps researchers learn which tumors are more likely to change and may lead to better care.
This study collects leftover brain or spinal tumor tissue during neurosurgery (or from autopsies) so researchers can test drugs and measure how they work. It may help future treatments by improving drug screening using real patient tissue.
Hear when a new Neurofibromatoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.